Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

D Samuel Colella

Affiliations

  • Director at Fluidigm Corp (FLDM), 2019-08-29
  • Large Shareholder, Director at Flexion Therapeutics Inc (FLXN), 2019-08-09
  • Other at Glaukos Corp (GKOS), 2016-06-03
  • Large Shareholder at Phaserx Inc. (PZRX), 2016-05-24
  • Large Shareholder at Inogen Inc (INGN), 2015-05-11
  • Large Shareholder at Second Sight Medical Products Inc (EYES), 2014-12-03
  • Director at Genomic Health Inc (GHDX), 2014-10-03
  • Large Shareholder, Director at Veracyte Inc. (VCYT), 2014-05-21
  • Other at Alexza Pharmaceuticals Inc. (ALXA), 2012-09-07
  • Director at Jazz Pharmaceuticals Inc (JAZZ), 2012-01-13
  • Large Shareholder at Helicos Biosciences Corp (HLCS), 2009-09-21
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
FLDM $5.19 2,000 Director 119,481 2019-08-27 Filing
FLDM $6.65 1,000 Director 117,481 2019-08-08 Filing
FLXN $10.74 2,000 Large Shareholder, Director 45,333 2019-08-08 Filing
FLDM $6.86 1,000 Director 116,481 2019-08-07 Filing
FLDM $7.02 8,000 Director 115,481 2019-08-06 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
FLDM $38.92 5,700 Director 19,673 2015-02-20 Filing
FLDM $38.97 38,840 Director 19,673 2015-02-19 Filing
FLDM $38.71 8,800 Director 19,673 2015-02-18 Filing
FLDM $19.89 10,655 Director 34,585 2013-08-14 Filing
FLDM $19.89 3,634 Director 11,797 2013-08-14 Filing